Differential expression of NF-κB heterodimer RelA/p50 in human urothelial carcinoma.

Background: Urothelial carcinoma (UC) is the fifth most common malignancy that accounts for 5% of all cancers. Diagnostic markers that predict UC progressions are inadequate. NF-κB contributes towards disease progression upon constitutive activation in many solid tumors.